Tricyclic Antidepressants Confirmation, Urine (Pain Management)
Use
Drug analysis/clinical drug monitoring
Special Instructions
Not provided.
Limitations
The Tricyclic Antidepressants Confirmation test is not cleared or approved by the FDA. The performance characteristics of this test were determined by Labcorp. Cross-reactivity may occur, especially with similar-structured compounds like Cyclobenzaprine, which, although included due to its structural similarity to TCAs, acts as a skeletal muscle relaxant rather than an antidepressant. Test interpretation requires careful consideration of the clinical context.
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 19315-1 - Tricyclics Ur Ql Cfm
- 19315-1 - Tricyclics Ur Ql Cfm
- 16225-5 - Amitrip Ur Ql Cfm
- 20515-3 - Amitrip Ur Cfm-mCnc
- 45144-3 - clomiPRAMINE Ur Ql
- 3492-6 - clomiPRAMINE Ur-mCnc
- 61409-9 - Cyclobenzaprine Ur Ql Cfm
- 61410-7 - Cyclobenzaprine Ur Cfm-mCnc
- 61415-6 - Doxepin Ur Ql Cfm
- 58014-2 - Nordoxepin Ur Ql
- 12386-9 - Nordoxepin Ur-mCnc
- 4084-0 - Trimipramine Ur Ql
- 12443-8 - Trimipramine Ur-mCnc
- 4001-4 - Protrip Ur Ql
- 26978-7 - Protrip Ur-mCnc
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
20 mL
Minimum Volume
7 mL
Container
Plastic urine container
Storage Instructions
Maintain specimen at room temperature. Stability: If arrival at lab will extend beyond seven days then refrigerate.
Other tests from different labs that may be relevant